This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Universidade Federal De Minas Gerais. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Washington Xavier De Paula: Innovator in Cardiovascular Treatments
Introduction
Washington Xavier De Paula is a notable inventor based in Belo Horizonte, Brazil. He has made significant contributions to the field of cardiovascular medicine through his innovative research and patent work. His dedication to improving health outcomes for patients with arterial hypertension and related conditions is commendable.
Latest Patents
Washington Xavier De Paula holds a patent for the "Preparation of formulations of angiotensin II AT1 receptors antagonists for the treatment of arterial hypertension, other cardiovascular illnesses and its complications." This patent describes inclusion compounds consisting of certain Angiotensin II AT1 receptors antagonists and cyclodextrins. These inclusion compounds are particularly useful in the treatment of hypertension, showcasing his commitment to advancing medical science.
Career Highlights
De Paula is affiliated with the Universidade Federal de Minas Gerais, where he continues to engage in research and development. His work has not only contributed to academic knowledge but also has practical implications for treating cardiovascular diseases.
Collaborations
Throughout his career, Washington Xavier De Paula has collaborated with esteemed colleagues, including Ruben Dario Sinisterra Millan and Robson Augusto Souza Dos Santos. These partnerships have enhanced the scope and impact of his research.
Conclusion
Washington Xavier De Paula is a distinguished inventor whose work in cardiovascular treatments has the potential to improve the lives of many patients. His innovative approach and dedication to research exemplify the spirit of invention in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
